International policies and challenges on the legalization of traditional medicine/herbal medicines in the fight against ...
Published in Pharmacological Research
Methodological education in response to the quality of COVID-19 publications.
Published in Pharmacological research
Anticoagulant or antiplatelet use and severe COVID-19 disease: A propensity score-matched territory-wide study
...Published in Pharmacological Research
Consumption of antibiotics at an Italian university hospital during the early months of the COVID-19 pandemic: Were all ...
...Published in Pharmacological research
Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19.
Published in Pharmacological research
Saliva sampling for chasing SARS-CoV-2: A Game-changing strategy
...Published in Pharmacological Research
Letter to the Editor in response to the articles 'Lianhuaqingwen exerts anti-viral and anti-inflammatory activities agai...
Published in Pharmacological research
Association between early treatment with Qingfei Paidu decoction and favorable clinical outcomes in patients with COVID-...
...Published in Pharmacological Research
The coronavirus disease 2019 (COVID-19) epidemic has been almost controlled in China under a series of policies, including “early diagnosis and early treatment”. This study aimed to explore the association between early treatment with Qingfei Paidu decoction (QFPDD) and favorable clinical outcomes. In this retrospective multicenter study, we includ...
Letter to the Editor in response to the article ‘Candidate drugs against SARS-CoV-2 and COVID-19’
Published in Pharmacological Research
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro
Published in Pharmacological Research
Schematic representation of TPC2 role, investigated through genetic ablation and drug blocker, in the inhibition of Coronaviruses release into the cells.
